Enhancing Capital’s Colgate-Palmolive CL Stock Holding History

Enhancing Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$341K	Hold	4,000	–	–	0.24%	69
2026 Q2	$367K	Hold	4,000	–	–	0.25%	68
2026 Q1	$341K	Hold	4,000	–	–	0.25%	71
2025 Q4	$316K	Hold	4,000	–	–	0.23%	76
2025 Q3	$320K	Hold	4,000	–	–	0.23%	74
2025 Q2	$364K	Hold	4,000	–	–	0.28%	76
2025 Q1	$375K	Hold	4,000	–	–	0.3%	76
2024 Q4	$364K	Buy	+4,000	New	+$382K	0.29%	74
2022 Q3	$276K	Hold	4,000	–	–	0.34%	65
2022 Q2	$321K	Hold	4,000	–	–	0.38%	59
2022 Q1	$303K	Hold	4,000	–	–	0.32%	67
2021 Q4	$341K	Buy	+4,000	New	+$312K	0.37%	63

Other funds holding CL

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Enhancing Capital's CL Position: Q3 2026 in Review

Enhancing Capital held its Colgate-Palmolive (CL) position steady in Q3 2026 at 4,000 shares worth $341K. The position accounts for 0.24% of the portfolio, ranked #69.

Enhancing Capital first reported a position in CL in Q4 2021 and has held it in 12 quarters since. The position peaked at $375K in Q1 2025. 756 funds tracked by Wall St. Rank hold CL as of Q3 2026.

Enhancing Capital held 4,000 shares of Colgate-Palmolive worth $341K as of Q3 2026.
Enhancing Capital left its Colgate-Palmolive share count unchanged in Q3 2026.
Colgate-Palmolive made up 0.24% of Enhancing Capital's portfolio in Q3 2026, its #69 holding.
Enhancing Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 12 quarters since.
Enhancing Capital's Colgate-Palmolive position peaked at $375K in Q1 2025.
756 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Enhancing Capital's 13F filing for Q3 2026, filed 26 Oct 2026.